Across its top 20 institutional holders, CVS's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 6/100, avg. turnover score 21/100).

Quarterly Activity

Recent Activity

+$39.7B

Total Buy Value

$45.1B

Total Sell Value

New buy129

Trim759

Add726

Sold out198

855

Net Buyers

957

Net Sellers

Smart Money Convergence

CVS does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/CVS

Insider Trading (Form 4)

12-Month Buy/Sell Activity

Feb 25

Jun 25

BuySell

Action	Insider	Title	Date	Value
Sell	Finucane Anne A.	Director	2025-08-20	$533K
Buy	SANSONE GUY P	Director	2025-06-05	$100K
Sell	ROBBINS LARRY	Director	2025-05-06	$10.00M
Sell	ROBBINS LARRY	Director	2025-05-05	$6.59M
Sell	ROBBINS LARRY	Director	2025-05-05	$82.66M
Sell	ROBBINS LARRY	Director	2025-05-02	$15.22M
Sell	ROBBINS LARRY	Director	2025-05-02	$113.20M
Sell	ROBBINS LARRY	Director	2025-05-02	$26.04M

View all insider trades →

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

126650100, 12665010 , 126650900, 126650950

FAQ

Who are the top institutional investors holding CVS HEALTH CORP (CVS)?

Major stakeholders currently include BlackRock, Inc. ($9.0B), Vanguard Capital Management LLC ($5.9B), Capital World Investors ($5.5B). Based on the latest 13F filings, there are a total of 1878 tracked investment funds and institutions maintaining positions in CVS.

What is the overall institutional sentiment toward CVS recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $1.2B, driven by 855 managers accumulating shares while 957 reduced their exposure.

Which institutions have been selling or reducing their CVS positions?

In the latest period, 759 funds trimmed their holdings, and 198 managers completely exited their positions. The aggregate reported sell value was $45.1B.

Are there any notable investors adding CVS to their portfolios?

Yes, buying activity remains notable. 129 institutions opened new positions in {ticker}, and 726 existing holders added to their shares. The total reported buy value for the quarter amounted to $39.7B.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,604

Total reported value

$438.9B

1706 institutions currently hold both CVS and this stock

View detail

LLY

Eli Lilly & Co

Institutions Holding

4,338

Total reported value

$730.5B

1650 institutions currently hold both CVS and this stock

View detail

ABBV

Abbvie INC

Institutions Holding

4,025

Total reported value

$283.9B

1642 institutions currently hold both CVS and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,151

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail

AMZN

Amazon.com INC

Institutions Holding

5,958

Total reported value

$1.5T

3029 13F institutions increased their position this quarter

View detail

NVDA

Nvidia CORP

Institutions Holding

5,766

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access CVS's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/CVS

CLI

npx alphasmo stocks get CVS

Full API & MCP documentation →